With more of us living into old age than at any other time, dementia is increasing steadily worldwide, with major individual, family, societal and economic…
Researchers have known that race and ethnicity play a role in the intensity of medical care at the end of life, but the difference is…
Enrolling representative populations in clinical trials for Alzheimer’s disease is critical for finding treatments that will be safe and effective for all patients. African Americans…
By using artificial intelligence, Houston Methodist researchers are able to predict hospitalization outcomes of geriatric patients with dementia on the first or second day of…
More than 60% of family caregivers of individuals with Alzheimer’s disease (AD) experienced at least mild depressive symptoms already at the time the individual with…
Every three seconds, someone in the world is diagnosed with dementia. And while there is no known cure, changes in the brain can occur years…
Dementia is a leading cause of death in Australia.
People with high blood pressure levels face a faster erosion of their ability to think, make decisions and remember information than those with normal blood…
Experts on Wednesday said they were encouraged after preliminary data for a new Alzheimer’s drug showed it slowed cognitive decline, the first medicine to accomplish…
Japanese drugmaker Eisai on Wednesday said its experimental drug lecanemab helped slow thinking declines among people in the early stages of Alzheimer’s disease.